Global Drug-Eluting Stents Market - Research and Markets

Report Scope:

This report examines the current and projected market potential of drug-eluting stents. It offers a detailed analysis of the regulatory scenario, competitive environment, pipeline, technological advancement, drivers, restraints and market growth trends. The report also includes market projections through 2024 and the market rank for key market players. The report details the market share of drug-eluting stents based on types of products, applications and end-user.

By product type, the market is segmented into polymer-based drug-eluting stents and polymer-free drug-eluting stents. By application, the market is segmented into coronary artery disease (CAD) and peripheral artery disease (PAD). By end-user, the market is segmented into hospitals, ambulatory surgical centers and specialty centers and clinics.

By geography, the market is segmented into North America, Europe, Asia-Pacific, Latin America and the Middle East and Africa. Detailed analyses of major countries such as the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China and India are covered in regional segments. For market estimates, data is provided for 2018 as the base year, 2019 and forecast through year-end 2024. Estimated values used are based on drug-eluting stent manufacturers’ total revenues. Projected and forecasted revenue values are in constant U.S. dollars that have not been adjusted for inflation.

The Report Includes:

20 data tables and 18 additional tables
An overview of the global market for drug-eluting stents within the medical devices industry
Estimation of the market size and analyses of market trends, with data from 2018 and 2019, and projections of compound annual growth rates (CAGRs) through 2024
Market share analysis of the drug-eluting stents based on product, application, end-use, and region
Identification of segments with high growth potential and analysis of future applications of each of the segments
Assessment of market dynamics for drug-eluting stents with market drivers and restraints explained, medical device regulations, market background and pipeline analysis of the stents
Coverage of prevalence and epidemiology of cardiovascular disease and description of coronary artery disease (CAD) and peripheral artery disease (PAD)
Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
Company profiles of the leading market players, including Abbott, B. Braun Melsungen AG, Biotronik SE & Co. KG, Boston Scientific Corp., Medtronic Plc and Cook Medical Inc.

Chapter 1 Introduction

Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
Custom Research
Related Research Reports

Chapter 2 Summary and Highlights

Market Highlights: Drug-Eluting Stents

Chapter 3 Medical Device Regulations

Medical Device Definition and Classification
Regulations in the U.S.
Code of Federal Regulations
Regulations in Europe
Regulations in Japan

Chapter 4 Drug-Eluting Stents: Pipeline Analysis

Overview

Chapter 5 Drug-Eluting Stents: Market Background

Introduction
Market Evolution
Coating and Polymers
Drugs Used in DESs
Cardiovascular Diseases (CVDs)
Common Types of CVD
Symptoms of CVD
Risk Factors: CVD
Treatment for CVD

Chapter 6 Drug-Eluting Stents: Market Dynamics

Market Dynamics
Market Drivers
Market Restraints

Chapter 7 Impact of COVID-19 Pandemic

Introduction
Outbreak
Symptoms of COVID-19
Progression of COVID-19
Incubation Period
Epidemiology
Global Confirmed COVID-19 Cases and Deaths
Collaboration Between Organizations and Governments
Spread of Disease
Current Status and Impact on MedTech
Elective and Noncritical Procedures
Shift in Manufacturing
Regulatory Delays, Clinical Trials and Product Launches
Supply Chain Disruptions
Medical Tourism

Chapter 8 Market Breakdown, by Product

Global Market for Drug-Eluting Stents, by Product
Polymer-Based Drug-Eluting Stents
Market Size and Forecast
Market Analysis
Polymer-Free Drug-Eluting Stents
Market Size and Forecast
Market Analysis

Chapter 9 Market Breakdown, by Application

Global Market for Drug-Eluting Stents, by Application
Coronary Artery Disease (CAD)
Market Size and Forecast
Market Analysis
Peripheral Artery Disease (PAD)
Market Size and Forecast
Market Analysis

Chapter 10 Market Breakdown, by End User

Global Market for Drug-Eluting Stents, by End User
Hospitals
Market Size and Forecast
Market Analysis
Ambulatory Surgical Centers
Market Size and Forecast
Market Analysis
Specialty Centers and Clinics
Market Size and Forecast
Market Analysis

Chapter 11 Market Breakdown, by Region

Global Market for Drug-Eluting Stents, by Region
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Rest of Asia-Pacific
Latin America
Middle East and Africa

Chapter 12 Competitive Landscape

Global Company Share Analysis
Mergers and Acquisitions
Agreements, Collaborations, Product Launches and Partnerships

Chapter 13 Company Profiles

Abbott
Alvimedica
B. Braun Melsungen Ag
Biosensors International
Biotronik Se & Co. Kg
Boston Scientific Corp.
Cook Medical Inc.
Lepu Medical Technology (Beijing) Co., Ltd.
Medtronic Plc
Terumo Corp.

Chapter 14 Appendix: List of Acronyms

List of Tables

Summary Table A: Global Market for Drug-Eluting Stents, by Product, Through 2024
Summary Table C: Global Market for Drug-Eluting Stents, by End User, Through 2024
Summary Table B: Global Market for Drug-Eluting Stents, by Application, Through 2024
Table 1: Class I and II Exempt Devices
Table 2: Selected Clinical Trial Studies: Drug-Eluting Stents
Table 3: Selected Coronary Stents
Table 4: Drugs Commonly Used in DES
Table 5: CVD Risk Factors
Table 6: Coronary Angioplasty Procedures, by Country, 2018
Table 7: Distribution of COVID-19 Symptoms
Table 8: COVID-19: Confirmed Cases and Deaths, by Country, as of Aug. 3, 2020
Table 9: Global Market for Drug-Eluting Stents, by Product Segment, Through 2024
Table 10: Common Polymers Used in DES
Table 11: Coating Methods to Develop Polymer-Free Drug-Eluting Stents
Table 12: Global Market for Drug-Eluting Stents, by Application, Through 2024
Table 13: Global Market for Drug-Eluting Stents, by End User, Through 2024
Table 14: Global Market for Drug-Eluting Stents, by Region, Through 2024
Table 15: North American Market for Drug-Eluting Stents, by Country, Through 2024
Table 16: Estimated Number of U.S. Stent Procedures, by Type of Procedure, 2014
Table 17: European Market for Drug-Eluting Stents, by Country, Through 2024
Table 18: Asia-Pacific Market for Drug-Eluting Stents, by Country, Through 2024
Table 19: Latin American Market for Drug-Eluting Stents, by Product, Through 2024
Table 20: Latin American Market for Drug-Eluting Stents, by Application, Through 2024
Table 21: Latin American Market for Drug-Eluting Stents, by End User, Through 2024
Table 22: Leading Causes of Death and Percentage Change in Argentina, 2007-2017
Table 23: Middle Eastern and African Market for Drug-Eluting Stents, by Product, Through 2024
Table 24: Middle Eastern and African Market for Drug-Eluting Stents, by Application, Through 2024
Table 25: Middle Eastern and African Market for Drug-Eluting Stent, by End User, Through 2024
Table 26: Global Market Shares of Drug-Eluting Stents, by Company, 2019
Table 27: Abbott: Drug-Eluting Stents, Product Portfolio
Table 28: Alvimedica: Drug-Eluting Stents, Product Portfolio
Table 29: B. Braun Melsungen AG: Drug-Eluting Stents, Product Portfolio
Table 30: Biosensors International: Drug-Eluting Stents, Product Portfolio
Table 31: Biotronik SE & Co. KG: Drug-Eluting Stents, Product Portfolio
Table 32: Boston Scientific Corp.: Drug-Eluting Stents, Product Portfolio
Table 33: Cook Medical Inc.: Drug-Eluting Stents, Product Portfolio
Table 34: Lepu Medical Technology (Beijing) Co., Ltd.: Drug-Eluting Stents, Product Portfolio
Table 35: Medtronic Plc: Drug-Eluting Stents, Product Portfolio
Table 36: Terumo Corp.: Drug-Eluting Stents, Product Portfolio
Table 37: Acronyms Used in the Drug-Eluting Stents Industry

List of Figures

Summary Figure C: Global Market for Drug-Eluting Stents, by Application, 2018-2024
Summary Figure B: Global Market Shares of Drug-Eluting Stents, by Product, 2019
Summary Figure A: Global Market for Drug-Eluting Stents, by Product, 2018-2024
Summary Figure D: Global Market Shares of Drug-Eluting Stents, by Application, 2019
Summary Figure E: Global Market for Drug-Eluting Stents, by End User, 2018-2024
Summary Figure F: Global Market Shares of Drug-Eluting Stents, by End User, 2019
Figure 1: Marketing a Medical Device in the U.S.
Figure 2: Historical Milestones: Coronary Artery Stenting
Figure 3: Global Disease Burden, 2017
Figure 4: Adults with Cardiovascular Conditions, by Country, 2019
Figure 5: Top 10 Global Causes of Deaths, 2016
Figure 6: Global Geriatric Population (Aged 65+ Years), 2014-2022
Figure 7: Surgical Operations Performed Globally, 2004 and 2012
Figure 8: Global Market Shares of Drug-Eluting Stents, by Product Segment, 2019
Figure 9: Global Market for Polymer-Based Drug-Eluting Stents, 2018-2024
Figure 10: Global Market for Polymer-Based Drug-Eluting Stents, by Region, 2018-2024
Figure 11: Global Market for Polymer-Free Drug-Eluting Stents, 2018-2024
Figure 12: Global Market for Polymer-Free Drug-Eluting Stents, by Region, 2018-2024
Figure 13: Global Market Shares of Drug-Eluting Stents, by Application, 2019
Figure 14: Global Market for Coronary Artery Disease, 2018-2024
Figure 15: Global Market for Peripheral Artery Disease, 2018-2024
Figure 16: Global Market Shares of Drug-Eluting Stents, by End User, 2019
Figure 17: Global Market for Drug-Eluting Stents in Hospital End Use, 2018-2024
Figure 18: Global Market for Drug-Eluting Stents in Ambulatory Surgical Center End Use, 2018-2024
Figure 19: Global Market for Drug-Eluting Stents in Specialty Center and Clinic End Use, 2018-2024
Figure 20: Global Market Shares of Drug-Eluting Stents, by Region, 2019
Figure 21: North American Market Shares of Drug-Eluting Stents, by Country, 2019
Figure 22: U.S. Market for Drug-Eluting Stents, 2018-2024
Figure 23: U.S. Population Aged 65+, Projection and Trends, 2010-2050
Figure 24: Distribution of Deaths in the U.S. from CVD, by Disease Sub-Segment, 2016
Figure 25: Canadian Market for Drug-Eluting Stents, 2018-2024
Figure 26: European Market Shares of Drug-Eluting Stents, by Country, 2019
Figure 27: German Market for Drug-Eluting Stents, 2018-2024
Figure 28: U.K. Market for Drug-Eluting Stents, 2018-2024
Figure 29: French Market for Drug-Eluting Stents, 2018-2024
Figure 30: Italian Market for Drug-Eluting Stents, 2018-2024
Figure 31: Spanish Market for Drug-Eluting Stents, 2018-2024
Figure 32: Rest of European Market for Drug-Eluting Stents, 2018-2024
Figure 33: Asia-Pacific Market Shares of Drug-Eluting Stents, by Country, 2019
Figure 34: Japanese Market for Drug-Eluting Stents, 2018-2024
Figure 35: Chinese Market for Drug-Eluting Stents, 2018-2024
Figure 36: Shares of Major Causes of Death in Rural China, 2016
Figure 37: Shares of Major Causes of Death in Urban China, 2016
Figure 38: Indian Market for Drug-Eluting Stents, 2018-2024
Figure 39: Rest of Asia-Pacific Market for Drug-Eluting Stents, 2018-2024
Figure 40: Latin American Market for Drug-Eluting Stents, 2018-2024
Figure 41: Latin American Market Shares of Drug-Eluting Stents, by Product, 2019
Figure 42: Middle Eastern and African Market for Drug-Eluting Stents, 2018-2024
Figure 43: Middle Eastern and African Market Shares of Drug-Eluting Stents, by Product, 2019
Figure 44: Abbott: Annual Revenue, 2017-2019
Figure 45: Abbott: Revenue Share, by Country, 2019
Figure 46: Abbott: Revenue Share, by Product Category, 2019
Figure 47: B. Braun Melsungen AG: Annual Revenue, 2017-2019
Figure 48: B. Braun Melsungen AG: Revenue Share, by Business Division, 2019
Figure 49: B. Braun Melsungen AG: Revenue Share, by Country/Region, 2019
Figure 50: Boston Scientific Corp.: Annual Revenue, 2017-2019
Figure 51: Boston Scientific Corp.: Revenue Share, by Product Category, 2019
Figure 52: Boston Scientific Corp.: R&D Expenditures, 2017-2019
Figure 53: Lepu Medical Technology (Beijing) Co., Ltd.: Annual Revenue, 2017-2019
Figure 54: Medtronic Plc: Annual Revenue, 2017-2019
Figure 55: Medtronic Plc: Revenue Share, by Country/Region, 2019
Figure 56: Medtronic Plc: Revenue Share, by Product Category, 2019
Figure 57: Terumo Corp.: Annual Revenue, 2017-2019
Figure 58: Terumo Corp.: Revenue Share, by Product Category, 2019

Executive Summary

The global market growth is attributed to the growing prevalence of cardiovascular diseases, a rise in the world’s geriatric population, and growing demand for minimally invasive procedures.

There has been remarkable growth in the development of coronary stents to avoid restenosis and thrombosis. Improvements include progress in the design and conformation of metallic or resorbable structures, with an adequate balance between trackability and radial force. Also noted is the development of antiproliferative drugs and polymers to control release and allow adequate endothelialization and optimal duration of the antiplatelet regimen. These developments led to growth in the drug-eluting stent market over the forecast period.

Drug-eluting stents are coated with a drug and polymer, designed to allow for a controlled and consistent release of the drug from the stent surface into the artery walls. Both the amount of drug and release rate has been determined so that healing can occur while allowing the processes leading to restenosis to be minimized, reducing the need for additional treatment in the stented area.

Rising incidence of CVD, heart failure, and coronary heart disease cases come with a growing prevalence of obesity, diabetes, and high blood pressure, globally. These phenomena are anticipated to fuel drug-eluting stents market growth over the forecast period.

Companies Mentioned

Abbott
Alvimedica
B. Braun Melsungen Ag
Biosensors International
Biotronik Se & Co. Kg
Boston Scientific Corp.
Cook Medical Inc.
Lepu Medical Technology (Beijing) Co., Ltd.
Medtronic Plc
Terumo Corp.

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€1326EUR$1,375USD£1,134GBP €2651EUR$2,750USD£2,267GBP
1 - 5 USER LICENSE PDF	The product is a PDF.	This is a 1-5 user license, allowing up to five users have access to the product.	€1591EUR$1,650USD£1,360GBP €3182EUR$3,300USD£2,721GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€1909EUR$1,980USD£1,633GBP €3818EUR$3,960USD£3,265GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€2291EUR$2,376USD£1,959GBP €4581EUR$4,752USD£3,918GBP

Table of Contents

Executive Summary

Companies Mentioned

Related Topics

Related Reports

Drug-Eluting Stents Market Report by Coating, Drug, Stent Platform, Generation, Application, End User, and Region 2024-2032

Drug Eluting Stent Market Size, Share & Trends Analysis Report By Coating Type (Polymer-based Coatings (Non-biodegradable, Biodegradable)), Polymer-free Coatings, By Application, By Region, And Segment Forecasts, 2023 - 2030

Global Drug Eluting Stent Market Size, Share & Industry Trends Analysis Report By Application (Coronary Artery Disease, and Peripheral Artery Disease), By Coating Type, By Regional Outlook and Forecast, 2023 - 2030

Global Drug Eluting Stent Market by Drug Coating (Polymer Free Coatings, Polymer-Based Coatings), Application (Coronary Artery Disease, Peripheral Artery Disease) - Forecast 2024-2030

Global Drug Eluting Stent Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028